ERBB2 and neoplasm: We found that the primary tumor biology (luminal B and HER2 positive), smaller BCBM size and surgical cavity, and non-cystic lesion, higher SRT dose, higher BED, and a shorter time gap from surgery to SRT, were significant for better local control.